Bank of Montreal
RNAC icon

Bank of Montreal’s Cartesian Therapeutics RNAC Stock Holding History

Bank of Montreal’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,743
Closed -$262K – 4118
2022
Q4 		$262K Sell
7,743
-27,414
-78% -$1.17M ﹤0.01% 2996
2022
Q3 		$2.3K Buy
+35,157
New +$1.93M ﹤0.01% 1740
2021
Q4 		– Sell
-20,317
Closed -$2.69M – 3817
2021
Q3 		$2.69M Buy
20,317
+8,428
+71% +$1.02M ﹤0.01% 1930
2021
Q2 		$1.78M Buy
11,889
+11,800
+13,258% +$1.41M ﹤0.01% 2124
2021
Q1 		$11K Sell
89
-436
-83% -$54.1K ﹤0.01% 4340
2020
Q4 		$51K Buy
525
+420
+400% +$36.4K ﹤0.01% 3927
2020
Q3 		$5K Sell
105
-77
-42% -$5.9K ﹤0.01% 4443
2020
Q2 		$15K Buy
+182
New +$16.5K ﹤0.01% 3985
2019
Q3 		– Sell
-1
Closed – – 4950
2019
Q2 		$0 Sell
1
-17
-94% -$1.16K ﹤0.01% 5041
2019
Q1 		$1K Buy
18
+10
+125% +$634 ﹤0.01% 4216
2018
Q4 		$1K Buy
8
+4
+100% +$913 ﹤0.01% 4554
2018
Q3 		$2K Hold
4
– – ﹤0.01% 4386
2018
Q2 		$2K Buy
+4
New +$1.42K ﹤0.01% 4390

Other funds holding RNAC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's RNAC Position: Q1 2023 in Review

Bank of Montreal sold out of Cartesian Therapeutics (RNAC) in Q1 2023, closing a stake of 7,743 shares — an estimated $262K sold.

Bank of Montreal first reported a position in RNAC in Q2 2018 and held it in 13 quarters. The position peaked at $2.69M in Q3 2021. 93 funds tracked by Wall St. Rank hold RNAC as of Q1 2023.

  • Bank of Montreal reported no remaining Cartesian Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 7,743 Cartesian Therapeutics shares in Q1 2023, an estimated $262K.
  • Bank of Montreal first reported a position in Cartesian Therapeutics in Q2 2018 and held it in 13 quarters.
  • Bank of Montreal's Cartesian Therapeutics position peaked at $2.69M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.